Phase 0 Clinical Trials: Conceptions and Misconceptions

Phase 0 clinical trials, developed in response to the United States Food and Drug Administration (FDA)’s recent exploratory Investigational New Drug (IND) guidance, are intended to expedite the clinical evaluation of new molecular entities. The exploratory IND supports the performance of first-in-hu...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer J
Auteurs principaux: Kummar, Shivaani, Rubinstein, Larry, Kinders, Robert, Parchment, Ralph E., Gutierrez, Martin E., Murgo, Anthony J., Ji, Jay, Mroczkowski, Barbara, Pickeral, Oxana K., Simpson, Mel, Hollingshead, Melinda, Yang, Sherry X., Helman, Lee, Wiltrout, Robert, Collins, Jerry, Tomaszewski, Joseph E., Doroshow, James H.
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7185299/
https://ncbi.nlm.nih.gov/pubmed/18536551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e318172d6f3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires